34999113|t|Mechanistic insight into the role of metformin in Alzheimer's disease.
34999113|a|Alzheimer's disease (AD), a type of dementia, is characterized by progressive memory decline and cognition impairment. Despite the considerable body of evidence regarding AD pathophysiology, current therapies merely slow down the disease progression, and a comprehensive therapeutic approach is unavailable. Accordingly, finding an efficient multifunctional remedy is necessary to blunt the increasing rate of AD incidence in the upcoming years. AD shares pathophysiological similarities (e.g., impairment of cognitive functions, insulin sensitivity, and brain glucose metabolism) with noninsulin-dependent diabetes mellitus (NIDDM), which offers the utilization of metformin, a biguanide hypoglycemic agent, as an alternative therapeutic approach in AD therapy. Emerging evidence has revealed the impact of metformin in patients suffering from AD. It has been described that metformin employs multiple mechanisms to improve cognition and memory impairment in pre-clinical AD models, including reduction of hippocampal amyloid-beta (Abeta) plaque and neurofibrillary tangles (NFTs) load, suppression of inflammation, amelioration of mitochondrial dysfunction and oxidative stress, restriction of apoptotic neuronal death, and induction of neurogenesis. This review discusses the pre-clinical evidence, which may shed light on the role of metformin in AD and provide a more comprehensive mechanistic insight for future studies in this area of research.
34999113	37	46	metformin	Chemical	MESH:D008687
34999113	50	69	Alzheimer's disease	Disease	MESH:D000544
34999113	71	90	Alzheimer's disease	Disease	MESH:D000544
34999113	92	94	AD	Disease	MESH:D000544
34999113	107	115	dementia	Disease	MESH:D003704
34999113	149	163	memory decline	Disease	MESH:D060825
34999113	168	188	cognition impairment	Disease	MESH:D003072
34999113	242	244	AD	Disease	MESH:D000544
34999113	481	483	AD	Disease	MESH:D000544
34999113	517	519	AD	Disease	MESH:D000544
34999113	566	599	impairment of cognitive functions	Disease	MESH:D003072
34999113	601	608	insulin	Gene	3630
34999113	632	639	glucose	Chemical	MESH:D005947
34999113	657	695	noninsulin-dependent diabetes mellitus	Disease	MESH:D003924
34999113	697	702	NIDDM	Disease	MESH:D003924
34999113	737	746	metformin	Chemical	MESH:D008687
34999113	750	759	biguanide	Chemical	MESH:D001645
34999113	822	824	AD	Disease	MESH:D000544
34999113	879	888	metformin	Chemical	MESH:D008687
34999113	892	900	patients	Species	9606
34999113	916	918	AD	Disease	MESH:D000544
34999113	947	956	metformin	Chemical	MESH:D008687
34999113	1010	1027	memory impairment	Disease	MESH:D008569
34999113	1044	1046	AD	Disease	MESH:D000544
34999113	1090	1102	amyloid-beta	Gene	351
34999113	1104	1109	Abeta	Gene	351
34999113	1122	1145	neurofibrillary tangles	Disease	MESH:D055956
34999113	1147	1151	NFTs	Disease	MESH:D055956
34999113	1174	1186	inflammation	Disease	MESH:D007249
34999113	1204	1229	mitochondrial dysfunction	Disease	MESH:D028361
34999113	1277	1291	neuronal death	Disease	MESH:D009410
34999113	1409	1418	metformin	Chemical	MESH:D008687
34999113	1422	1424	AD	Disease	MESH:D000544
34999113	Negative_Correlation	MESH:D008687	MESH:D007249
34999113	Negative_Correlation	MESH:D008687	MESH:D028361
34999113	Positive_Correlation	MESH:D008687	MESH:D008569
34999113	Negative_Correlation	MESH:D008687	MESH:D009410
34999113	Negative_Correlation	MESH:D008687	MESH:D000544
34999113	Negative_Correlation	MESH:D001645	MESH:D000544
34999113	Negative_Correlation	MESH:D008687	351
34999113	Negative_Correlation	MESH:D008687	MESH:D055956
34999113	Association	MESH:D005947	MESH:D000544
34999113	Association	MESH:D000544	3630

